CSH1

CSH1 encodes a placental somatomammotropin/lactogen hormone whose expression is restricted to syncytiotrophoblasts and is governed by a layered transcriptional program operating on the hGH/CS gene locus (PMID:29763375, PMID:12573257). Hormone production is driven by trophoblast differentiation: induction of CSH1 protein requires downregulation of the stem cell factor ID2 and upregulation of HAND1/Eomes, events controlled downstream of MAPK8/9 (JNK) and PRKAA1/2 (AMPK) stress-kinase signaling, with JNK governing HAND1/Eomes and AMPK governing ID2 loss (PMID:20422711, PMID:21710638). The homeodomain factor NECC1 acts upstream to push choriocarcinoma cells toward the syncytiotrophoblast lineage and induce CSH1 (PMID:12573257), while hypoxia blocks both ID2 loss and CSH1 induction (PMID:16481593). Locus expression is positively modulated by thyroid hormone (T3) (PMID:1708334) and by the transcription factor Pit-1, which binds and activates the hCS-A promoter (PMID:8735586). Transcription depends on a placenta-specific chromosomal architecture at the locus: this conformation, together with RNA Pol II and C/EBPβ occupancy at hCS promoters and enhancers, is disrupted by maternal obesity and partially restored by insulin (PMID:29763375). The locus is repressed by the paternally-expressed factor PEG3, which binds locus control region hypersensitive sites (HS III–V) (PMID:40147358), and is negatively modulated by the chromatin remodeler RYBP (PMID:40424181). Outside the placenta, CSH1 mRNA is detectable in breast cancer but an inhibitory mechanism blocks its translation at endogenous levels, so no hormone protein is produced (PMID:24475273).

1. 1990 Medium

   Established that differential CS/GH-V gene expression is set at the level of promoter strength, attributing higher hCS-A output to a transcription factor binding a proximal promoter element absent in hGH-V.

   Evidence Stable transfection and hybrid promoter constructs in rat GC pituitary cells with promoter-binding assays

   PMID:2339980

   Open questions at the time

   • Identity of the bound factor not resolved in placental cells
   • Heterologous pituitary cell context may not reflect trophoblast regulation
2. 1991 Medium

   Showed CSH1 expression is hormonally inducible, with thyroid hormone raising hCS mRNA and secreted protein in placental-like cells.

   Evidence T3 treatment of BeWo choriocarcinoma cells with Northern and Western analysis

   PMID:1708334

   Open questions at the time

   • T3 receptor binding site at the locus not mapped
   • Direct versus indirect T3 action not distinguished
3. 1993 Medium

   Demonstrated that T3 responsiveness of the locus can be uncoupled from receptor binding, since methotrexate blunts T3 induction without altering T3 receptor number or affinity.

   Evidence MTX plus T3 treatment of BeWo cells with RNA blotting and receptor binding assays

   PMID:8472847

   Open questions at the time

   • Downstream step targeted by MTX not identified
   • Mechanism remains correlative
4. 1996 Medium

   Identified Pit-1 as a candidate placental regulator, showing it is locally expressed in trophoblast and can bind and activate the hCS-A promoter.

   Evidence RT-PCR, in situ hybridization, immunohistochemistry, and promoter activation in rat placenta

   PMID:8735586

   Open questions at the time

   • No loss-of-function test of Pit-1 requirement for CSH1
   • Relevance to human placenta not established
5. 2003 Medium

   Placed the homeodomain factor NECC1 upstream of CSH1 in trophoblast differentiation by showing it induces CSH1 and drives syncytiotrophoblast morphology.

   Evidence NECC1 transfection into choriocarcinoma lines with CSH1 expression and morphological readout

   PMID:12573257

   Open questions at the time

   • Direct versus differentiation-mediated induction not separated
   • NECC1 binding at the locus not shown
6. 2006 Medium

   Linked the microenvironment to CSH1 by showing hypoxia blocks CSH1 protein induction and prevents Id2 downregulation during giant cell differentiation.

   Evidence Normoxic versus hypoxic Rcho-1 culture with RT-PCR, Western blot, and immunofluorescence

   PMID:16481593

   Open questions at the time

   • Oxygen-sensing pathway connecting to Id2 not defined
   • Rodent trophoblast model
7. 2011 Medium

   Mapped the stress-kinase signaling controlling CSH1 induction, dissecting JNK control of Eomes/HAND1 from AMPK control of ID2 loss, with combined inhibition most strongly suppressing CSH1.

   Evidence Pharmacological JNK and AMPK inhibitors under stress in trophoblast stem cells with immunoblot/immunocytochemistry (extends 20422711)

   PMID:20422711 PMID:21710638

   Open questions at the time

   • Direct transcriptional targets of HAND1/Eomes at the locus not shown
   • Inhibitor specificity limits causal assignment
8. 2018 High

   Demonstrated that CSH1 transcription depends on a placenta-specific 3D chromosomal architecture and that maternal obesity disrupts this structure, reducing CSH1 RNA, Pol II, and C/EBPβ occupancy, with insulin partially restoring it.

   Evidence Chromosome conformation capture, ChIP for Pol II and C/EBPβ, and qRT-PCR across lean, obese, and insulin-treated human placentas

   PMID:29763375

   Open questions at the time

   • Causal architecture-driving factor not identified here
   • Mechanism by which obesity alters conformation unresolved
9. 2025 High

   Identified PEG3 as a paternally-expressed repressor of CSH1 that binds locus control region hypersensitive sites, with knockdown increasing hCS expression and elevated PEG3 binding correlating with reduced CSH1 in obese placentas.

   Evidence ChIP, siRNA knockdown, 3C, and human tissue comparison in JEG-3 cells and term placenta

   PMID:40147358

   Open questions at the time

   • How PEG3 binding alters locus architecture not fully resolved
   • Interplay with C/EBPβ and Pol II occupancy not directly tested
10. 2025 Medium

    Defined the chromatin remodeler RYBP as a regulator upstream of CSH1, since RYBP knockout downregulates CSH1 while upregulating oxygen-sensing genes in trophoblast organoids.

    Evidence Single-nucleus RNA-seq and RYBP knockout in trophoblast organoids with gene regulatory network analysis

    PMID:40424181

    Open questions at the time

    • Direct RYBP occupancy at the CSH1 locus not shown
    • Mechanistic link between RYBP and oxygen-sensing gene program unclear
11. 2014 Medium

    Established that CSH1 mRNA expression outside the placenta does not yield hormone protein, revealing a translational block in breast cancer where mRNA is present but protein is undetectable absent massive overexpression.

    Evidence qRT-PCR, shRNA knockdown, custom monoclonal Western blots, and IHC in breast cancer lines and tumors

    PMID:24475273

    Open questions at the time

    • Molecular identity of the translational inhibitory mechanism unknown
    • Whether the same block operates in other non-placental tissues untested

• The hormone's own downstream receptor signaling, physiological target tissues, and the molecular basis of the non-placental translational block remain uncharacterized in this corpus.
• No receptor or downstream signaling partner identified
• Translational inhibitor in non-placental cells not molecularly defined
• No structural or biochemical characterization of the secreted hormone